| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 08/06/2007 | 18:51 | PR Newswire (US) | Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc. | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 05/06/2007 | 21:58 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2007 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 29/05/2007 | 18:00 | PR Newswire (US) | Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 09/05/2007 | 16:00 | PR Newswire (US) | Boston Life Sciences to Host 2007 1st Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/05/2007 | 16:30 | PR Newswire (US) | Boston Life Sciences Raises $6 Million Through Issuance of a Convertible Promissory Note to a New Fund | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 01/05/2007 | 17:44 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 2007 Biotechnology Industry Organization's (BIO) Annual BIO International Conventio | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 17/04/2007 | 16:00 | PR Newswire (US) | Boston Life Sciences Reports New Option Grants Under NASDAQ Market Rule 4350 | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 16/04/2007 | 18:57 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the Americ | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 16/04/2007 | 16:00 | PR Newswire (US) | Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 12/04/2007 | 22:22 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Data to be Presented on Cethrin(R) for Spinal Cord Injury at the 2007 American Association | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/04/2007 | 23:07 | PR Newswire (US) | Boston Life Sciences, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 29/03/2007 | 17:45 | PR Newswire (US) | Boston Life Sciences To Host 2006 4th Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 27/03/2007 | 17:33 | PR Newswire (US) | Boston Life Sciences Completes Final License Fee Payment for Exclusive, Worldwide Rights to Develop and Commercialize Phase II S | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 26/03/2007 | 21:55 | PR Newswire (US) | Boston Life Sciences Enters Into $15 Million Convertible Promissory Note Purchase Agreement and Amends Existing Promissory Notes | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 22/03/2007 | 16:25 | PR Newswire (US) | Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 07/03/2007 | 17:00 | PR Newswire (US) | Boston Life Sciences, Inc. To Present at the Sachs Associates 6th Annual North America Forum for Investing & Partnering in Biote | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 13/02/2007 | 20:55 | PR Newswire (US) | Boston Life Sciences Issues Amended Promissory Notes for Up to an Additional $2 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 07/02/2007 | 16:28 | PR Newswire (US) | Boston Life Sciences, Inc. to Participate in the 2007 BIO CEO & Investor Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 06/02/2007 | 20:43 | PR Newswire (US) | Boston Life Sciences Announces the Appointment of Henry Brem, M.D. and Gary Frashier to the Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 01/02/2007 | 17:07 | PR Newswire (US) | Boston Life Sciences Sponsors Movement Disorder Society's 1st Annual Neuroimaging in Parkinson's Disease Symposium | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/01/2007 | 15:26 | PR Newswire (US) | Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exc | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 13/12/2006 | 19:32 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2006 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 06/11/2006 | 15:17 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the CIBC World Markets 17th Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/11/2006 | 18:39 | PR Newswire (US) | Boston Life Sciences Issues Promissory Notes for Up to $8 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 31/10/2006 | 17:12 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Rodman & Renshaw Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 30/10/2006 | 22:21 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Mass Biotech Council's Mass Opportunities Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 25/09/2006 | 18:33 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 30/08/2006 | 17:10 | PR Newswire (US) | Peter Savas, Chairman and CEO of Boston Life Sciences, Inc., Scheduled to Appear on New England Cable News 'New England Busines | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 10/08/2006 | 22:46 | PR Newswire (US) | Boston Life Sciences, Inc. Announces the Issuance of a U.S. Patent Licensed to BLSI by Harvard et al that Covers Methods for th | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 27/07/2006 | 16:31 | PR Newswire (US) | Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |